Fathom Therapeutics
Latest round
- Series A
Last raised
- Nov 2026
Total raised
- $86M
Investors
- 5
About Fathom Therapeutics
Based in the US, Fathom Therapeutics specializes in advanced molecular solutions that tackle critical challenges in drug development and biotechnology, enhancing molecular analysis for improved therapeutic discovery and diagnostics. Fathom Therapeutics, founded in 2023 by Dr. Huafeng Xu. Based in New York, US, focuses on molecular technologies for drug development and biotechnology. Fathom Therapeutics specializes in advanced molecular solutions designed to address significant challenges in drug development and biotechnology. Their core product offerings feature proprietary technologies that enhance molecular analysis, enabling researchers and pharmaceutical companies to streamline workflows and improve the accuracy of their findings. These technologies are utilized in therapeutic discovery, diagnostics, and personalized medicine, serving clients in the healthcare and life sciences sectors, including biopharmaceutical firms and academic research institutions across North America, Europe, and parts of Asia. Fathom Therapeutics generates revenue through a structured model involving direct partnerships with B2B clients. Transactions are typically based on subscription access to its molecular technologies, allowing clients to utilize advanced tools for research and development. The company also engages in collaborative projects with pharmaceutical firms that include milestone payments tied to research progress. Their pricing structure is aligned with the value provided, offering tiered plans for various scales of research operations. The company is also targeting expansion into new markets, specifically in Europe and parts of Asia, by 2027 to broaden its customer base and enhance its global presence.
Who invested in Fathom Therapeutics
5 investors across 2 rounds
See all investors in Fathom Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Fathom Therapeutics
Who invested in Fathom Therapeutics?
Fathom Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fathom Therapeutics raised?
Fathom Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Fathom Therapeutics last raise money?
Fathom Therapeutics's most recent round on record is a Series A, in Nov 2026.
What does Fathom Therapeutics do?
Based in the US, Fathom Therapeutics specializes in advanced molecular solutions that tackle critical challenges in drug development and biotechnology, enhancing molecular analysis for improved therapeutic discovery and diagnostics.
Where is Fathom Therapeutics headquartered?
Fathom Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Fathom Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Fathom Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Fathom Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.